3 ways artificial intelligence is tackling cancer

cancer
Image credit: Pravdareport

Case Study 1: The Sharing Project

[Jinghui Zhang wondered] how much faster cancer research could move if data sets were freely and immediately available to computational biologists who wanted to work on them, so in April she partnered with Microsoft to release St. Jude Cloud, a web-based data processor that offers access—within 48 hours—to the largest publicly available set of childhood cancer stats in the world, the whole genomes of more than 5,000 St. Jude patients.

Case Study 2: Machine Learning for Doctors

In January 2018, Microsoft also partnered with the charity Stand Up to Cancer on an $11 million research program called Convergence 2.0 to solve a problem that is essentially the reverse of the one Zhang faced: researchers who have data sets or ideas worth studying, but little or no computer programming expertise.

Convergence 2.0 funded seven teams of researchers and medical doctors, matching each with machine-learning experts from places like Microsoft and MIT.

Case Study 3: Sharable Tumor Samples

Meanwhile, for clinicians, a new company called Paige.AI made an agreement with Memorial Sloan Kettering Cancer Center in New York to train machine-learning algorithms on its absolutely massive collection of 25 million digitized tumor slides. The software will eventually be able to help doctors all over the country diagnose cancer from biopsies the same way a top MSK pathologist would.

Read full, original post: Cancer Has a New Enemy: A.I.

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

Screenshot-2026-04-20-at-2.26.27-PM
Viewpoint — Food-fear world: The latest activist scientists campaign: Cancer-causing additives
Screenshot-2026-03-13-at-12.14.04-PM
The FDA wants to make many popular prescription drugs OTC—a great idea. Here’s why it’s unlikely to happen
Screenshot-2026-05-04-at-12.54.32-PM
How Utah became the country’s supplement capital  — and a haven for unregulated, ineffective and fake products
Screenshot-2026-05-01-at-11.56.24-AM
‘Science moves forward when people are willing to think differently’: Memories of DNA maverick Craig Venter
Screenshot-2026-04-03-at-11.15.51-AM
Paraben panic: How a flawed study, media hype, and chemophobia convinced the public of the danger of one of the safest classes of preservatives
ChatGPT-Image-May-1-2026-02_20_13-PM
How RFK, Jr.’s false vaccine claims are holding up $600 million to fight diseases in poor countries
Screenshot-2026-04-30-at-2.19.37-PM
5 myths about summer dehydration that could damage your health — or even kill you
ChatGPT-Image-Mar-27-2026-11_27_05-AM
The myths of “process”: What science says about the “dangers’ of synthetic products and ultra-processed foods
viva-la-vida-watermelons
Misinformation and climate change are endangering summer watermelons
Drinking lots of water can help reduce the effects of aging
Nanoplastics in drinking water: MAHA activists forge science-based bipartisan coalition 
circular-bioeconomy-should-focus-on-sustainable-wellbeing
GLP podcast: What's wrong with 'doomsday' environmentalism? It's false.
ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.